The new study could help determine how brain network patterns may change once consumers reduce their cannabis intake.
The small study observed that children given CBD showed fewer behavioral problems, such as aggression and self-injury.
The cost of the medications has been capped at £150 ($187 dollars US) per month for the participants – a price roughly equivalent to what consumers pay in the country’s illicit market.
The platform will include free educational webinars that cover the latest evidence for medical cannabis treatments, dosing and monitoring, modes of administration, and key case study examples.
Members of the industry group will be able to offer up their own CBD products for safety tests, which will range from contaminant analysis to experimental rodent studies.